140 related articles for article (PubMed ID: 32255248)
1. Effect of Regiochemistry and Methylation on the Anticancer Activity of a Ferrocene-Containing Organometallic Nucleoside Analogue.
Ismail MK; Khan Z; Rana M; Horswell SL; Male L; Nguyen HV; Perotti A; Romero-Canelón I; Wilkinson EA; Hodges NJ; Tucker JHR
Chembiochem; 2020 Sep; 21(17):2487-2494. PubMed ID: 32255248
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the antitumor activity of a cyclopalladated ferrocene compound assisted by a dual-targeting drug delivery system.
Gong G; Cao Y; Qian H; Zhou Y; Zhao H; Li L; Wang F; Zhao G
Chem Commun (Camb); 2018 Jul; 54(60):8312-8315. PubMed ID: 29868665
[TBL] [Abstract][Full Text] [Related]
3. The in Vitro Antiplasmodial and Antiproliferative Activity of New Ferrocene-Based α-Aminocresols Targeting Hemozoin Inhibition and DNA Interaction.
Mbaba M; Dingle LMK; Swart T; Cash D; Laming D; de la Mare JA; Taylor D; Hoppe HC; Biot C; Edkins AL; Khanye SD
Chembiochem; 2020 Sep; 21(18):2643-2658. PubMed ID: 32307798
[TBL] [Abstract][Full Text] [Related]
4. Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties.
Mu C; Prosser KE; Harrypersad S; MacNeil GA; Panchmatia R; Thompson JR; Sinha S; Warren JJ; Walsby CJ
Inorg Chem; 2018 Dec; 57(24):15247-15261. PubMed ID: 30495936
[TBL] [Abstract][Full Text] [Related]
5. The Antiproliferative Activity of Ferrocene Derivatives against Drug- Resistant Cancer Cell Lines: A Mini Review.
Li L; Ma L; Sun J
Curr Top Med Chem; 2021; 21(19):1756-1772. PubMed ID: 34323188
[TBL] [Abstract][Full Text] [Related]
6. Organometallic nucleoside analogues with ferrocenyl linker groups: synthesis and cancer cell line studies.
Nguyen HV; Sallustrau A; Balzarini J; Bedford MR; Eden JC; Georgousi N; Hodges NJ; Kedge J; Mehellou Y; Tselepis C; Tucker JH
J Med Chem; 2014 Jul; 57(13):5817-22. PubMed ID: 24905419
[TBL] [Abstract][Full Text] [Related]
7. Novobiocin-ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition.
Mbaba M; de la Mare JA; Sterrenberg JN; Kajewole D; Maharaj S; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
J Biol Inorg Chem; 2019 Mar; 24(2):139-149. PubMed ID: 30542925
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, docking, machine learning and antiproliferative activity of the 6-ferrocene/heterocycle-2-aminopyrimidine and 5-ferrocene-1H-Pyrazole derivatives obtained by microwave-assisted Atwal reaction as potential anticancer agents.
Filho EV; Pina JWS; Antoniazi MK; Loureiro LB; Ribeiro MA; Pinheiro CB; Guimarães CJ; de Oliveira FCE; Pessoa C; Taranto AG; Greco SJ
Bioorg Med Chem Lett; 2021 Sep; 48():128240. PubMed ID: 34217828
[TBL] [Abstract][Full Text] [Related]
9. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
10. Organometallic nucleoside analogues: effect of the metallocene metal atom on cancer cell line toxicity.
Ismail MK; Armstrong KA; Hodder SL; Horswell SL; Male L; Nguyen HV; Wilkinson EA; Hodges NJ; Tucker JHR
Dalton Trans; 2020 Jan; 49(4):1181-1190. PubMed ID: 31897458
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of heterobimetallic gold(i) ferrocenyl-substituted 1,2,3-triazol-5-ylidene complexes as potential anticancer agents.
Aucamp D; Kumar SV; Liles DC; Fernandes MA; Harmse L; Bezuidenhout DI
Dalton Trans; 2018 Nov; 47(45):16072-16081. PubMed ID: 30276400
[TBL] [Abstract][Full Text] [Related]
12. Ferrocene-Containing Impiridone (ONC201) Hybrids: Synthesis, DFT Modelling, In Vitro Evaluation, and Structure⁻Activity Relationships.
Bárány P; Oláh RS; Kovács I; Czuczi T; Szabó CL; Takács A; Lajkó E; Láng O; Kőhidai L; Schlosser G; Bősze S; Mező G; Hudecz F; Csámpai A
Molecules; 2018 Sep; 23(9):. PubMed ID: 30177664
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy.
Ren SZ; Wang ZC; Zhu D; Zhu XH; Shen FQ; Wu SY; Chen JJ; Xu C; Zhu HL
Eur J Med Chem; 2018 Sep; 157():909-924. PubMed ID: 30149323
[TBL] [Abstract][Full Text] [Related]
14. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships.
Wang R; Chen H; Yan W; Zheng M; Zhang T; Zhang Y
Eur J Med Chem; 2020 Mar; 190():112109. PubMed ID: 32032851
[TBL] [Abstract][Full Text] [Related]
15. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
[TBL] [Abstract][Full Text] [Related]
16. A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway.
Noori S; Nourbakhsh M; Farzaneh S; Zarghi A
Anticancer Agents Med Chem; 2020; 20(18):2285-2292. PubMed ID: 32767949
[TBL] [Abstract][Full Text] [Related]
17. Ferrocene-appended pharmacophores: an exciting approach for modulating the biological potential of organic scaffolds.
Singh A; Lumb I; Mehra V; Kumar V
Dalton Trans; 2019 Feb; 48(9):2840-2860. PubMed ID: 30663743
[TBL] [Abstract][Full Text] [Related]
18. Ferrocenyl and organic novobiocin derivatives: Synthesis and their in vitro biological activity.
Mbaba M; Mabhula AN; Boel N; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
J Inorg Biochem; 2017 Jul; 172():88-93. PubMed ID: 28441548
[TBL] [Abstract][Full Text] [Related]
19. Cyclopentadienyl-ruthenium(II) and iron(II) organometallic compounds with carbohydrate derivative ligands as good colorectal anticancer agents.
Florindo PR; Pereira DM; Borralho PM; Rodrigues CM; Piedade MF; Fernandes AC
J Med Chem; 2015 May; 58(10):4339-47. PubMed ID: 25923600
[TBL] [Abstract][Full Text] [Related]
20. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research.
Ge X; Chen S; Liu X; Wang Q; Gao L; Zhao C; Zhang L; Shao M; Yuan XA; Tian L; Liu Z
Inorg Chem; 2019 Oct; 58(20):14175-14184. PubMed ID: 31559820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
